How has the evidence base changed in support of RDN since the HTN 3 study was released?
Hypertension and Renal Denervation. This resource helps non-invasive cardiologists, hypertension specialists, general practitioners, and nephrologists understand the benefits of Renal Denervation...
Hypertension and Renal Denervation. This resource helps non-invasive cardiologists, hypertension specialists, general practitioners, and nephrologists understand the benefits of Renal Denervation as an adjunctive therapy for treating Hypertension.
It answers frequently asked questions with the latest expert opinions, guideline summaries, and essential information for practical adoption in managing uncontrolled and resistant Hypertension.
Learn about patient selection, key evidence for safety, effectiveness, durability, and integrating Renal Denervation into your practice.
Supported by an educational grant from Medtronic.
Speakers
Ajay Kirtane
Speaker
Ajay J. Kirtane, MD, SM, is a Professor of Medicine at Columbia University Medical Center and... Ajay J. Kirtane, MD, SM, is a Professor of Medicine at Columbia University Medical Center and Director of the Cardiac Catheterization Laboratories at New York Presbyterian Hospital. Dr. Kirtane is a graduate of Princeton University and Columbia University College of Physicians and Surgeons, and completed his residency in Internal Medicine at the University of California – San Francisco. Dr. Kirtane is a practicing Cardiologist with an interest in coronary and peripheral intervention and assumed the directorship of the NYP/Columbia cardiac catheterization laboratories in 2015. In addition to his clinical commitments at CUMC, Dr. Kirtane has a strong interest in clinical education and research, serving as Chief Academic Officer of the Center for Interventional Vascular Therapy. On the national and international level, he is a co-director of the Cardiovascular Research Foundation’s Transcatheter Cardiovascular Therapeutics meeting, has served as a director of several international, national, and regional educational meetings, and has participated on the program committees for the scientific sessions of both the American College of Cardiology and American Heart Association. Dr. Kirtane’s research interests are in clinical trial methodology and outcomes of device-based and pharmacologic interventions in Interventional Cardiology. He has authored/co-authored >150 original manuscripts and >50 reviews and chapters including the “Coronary Stenting” chapters of the two most widely used textbooks in Interventional Cardiology.
